MamaMancini's Holdings, Inc. (MMMB: OTCQB) | Chairman of
Top 10 Most Recent News Articles
EFICYENT Ventures to Connect at Singapore FinTech Fest
Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...
Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices
Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...
Continue Reading
WeFetch AI: A New Era in Barcode Precision
WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...
Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years
A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...
Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart
A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...
Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes
Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....
Continue Reading
Class Action Greenlighted Against Concordia for Title IX Violations
Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...
Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance
Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...
Continue Reading
Dana Concludes Tender Offers for Senior Notes
An Investor's Glance at Dana's Strategic Moves Dana Incorporated (NYSE: DAN) just pulled a bold move with their tender offers, snapping up a hefty $357,873,000 in outstanding principal on their senior notes. This isn’t just pocket change; folks holding out for securities can feel the tension of watching big numbers get shuffled around. You gotta wonder, what's the play...
Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results
Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...
Continue ReadingTop 5 Most Recently Viewed Articles
Join the Semtech Corporation Class Action for Investor Rights
Understand the Semtech Corporation Class Action Lawsuit Investors in Semtech Corporation, a well-known player in the semiconductor industry, are now being notified of a class action lawsuit. This legal matter aims to seek justice for those adversely affected by alleged securities fraud. The law firm Levi & Korsinsky, LLP is leading this initiative, reaching out to...
Continue Reading
Gary P. Gilroy Receives Prestigious Music Award in 2025
Celebrating a Music Education Legend In an exciting development for music education, Gary P. Gilroy, a distinguished Professor of Music Emeritus and Director of Bands Emeritus at California State University, Fresno, has been recognized for his outstanding contributions in this field. He was recently awarded the prestigious George N. Parks Award for Leadership in Music...
Continue Reading
Tech CEO Advocates for Honest Conversations on AI Job Impact
Embracing AI Transparency in the Workplace As technology continues to progress rapidly, it's crucial for leaders to prioritize clear communication about how artificial intelligence is affecting the job market. Recently, Jim Kavanaugh, the CEO of World Wide Technology, highlighted that employees are smart enough to see through any misleading narratives surrounding AI's...
Continue Reading
Innocan Pharma Expands Patent Reach in Asian Markets for CBD
Innocan Pharma's Expansion in Asian Markets Innocan Pharma Corporation, a key player in the pharmaceutical and biotechnology arenas, has taken significant strides in its efforts to expand its intellectual property coverage for its innovative liposomal CBD injection. This strategic development focuses on the expansive Asian pharmaceutical market, particularly highlighting...
Continue Reading
CYFOX Unveils Innovative Email Security for Microsoft 365
CYFOX Introduces Groundbreaking Email Security Solution CYFOX, a forward-thinking cybersecurity company, has recently launched an advanced email security solution that integrates seamlessly with Microsoft 365. This innovative framework eliminates the hassle of MX record adjustments and domain-level alterations, making it easier for organizations to enhance their email...
Continue Reading